Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-021547
Filing Date
2017-05-19
Accepted
2017-05-19 16:12:05
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5123
  Complete submission text file 0001140361-17-021547.txt   6598
Mailing Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065
Business Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIGA TECHNOLOGIES, INC. 35 EAST 62ND STREET NEW YORK NY 10065
Business Address
STERN ANDREW L (Reporting) CIK: 0001494422 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 17857936